Introduction
Adnexal masses are common and may present symptomatically with pelvic or abdominal pain or may be identified incidentally during the course of imaging for another indication. The majority of adnexal masses are benign, but a small number will be borderline tumors or invasive cancer. In the case of a benign lesion, the aim is to reassure the patient and manage according to the clinical need, without subjecting the patient to over-extensive or inappropriate surgery [1] . Conversely, in cases that demonstrate features with a higher likelihood of ovarian malignancy, referral to a specialist center will ensure the best possible outcome for the patient.
One major difficulty is that undertaking a biopsy to confirm the nature of an adnexal mass is not advised, if there is no peritoneal disease beyond the ovary. Biopsy could result in spillage of a potentially confined tumor and increase stage and risk for patient. Therefore, the clinical decision on how aggressively to manage the ovarian mass relies on the available clinical and image findings, rather than histology.
The clinical context at the time of presentation is relevant. The age and menopausal status of the patient and the presence of acute or chronic pain or fever may inform the interpretation of image findings. In premenopausal women with pain, a pregnancy test is indicated in order to rule out possible ectopic pregnancy as a cause of an adnexal mass.
Ultrasound is the first-line imaging modality, allowing the characterization of most adnexal masses. MRI is indicated in the characterization of sonographically indeterminate masses, whereas CT is indicated for further staging of a suspected ovarian cancer on US.
8.2
Imaging Modalities to Assess an Adnexal Mass
Ultrasound (US)
Optimally, transvaginal ultrasound (TVUS) and transabdominal ultrasound (TAUS) are combined to provide characterization of the adnexal mass and its differentiation from the uterus or other pelvic abnormalities. TAUS also provides information of ancillary findings that may be crucial for the diagnosis, e.g., presence of peritoneal implants, ascites, pleural effusion, and lymph node enlargement, and assessment of the kidneys and the bowels. For characterization of an adnexal mass, the following imaging features indicative of malignancy have been widely used: wall irregularity, thick septations (3 mm), papillary projections, solid components, and large size (4 cm) [1] [2] [3] . Unfortunately these features overlap with those of benign pathologies, e.g., tubo-ovarian abscess, corpus luteum cyst, endometriomas, and some rare benign tumors. Recently, the IOTA simple rules model has been introduced to preoperatively assess adnexal masses with US. Five sonographic imaging features each defining the B (benign) and M (malignant) categories are used to distinguish
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Magnetic Resonance Imaging (MRI)
MRI is recommended as a second-line imaging technique to evaluate adnexal masses that remain indeterminate on US [7] . MRI combines excellent contrast resolution and lack of nonionizing radiation, which is of utmost importance in children and in the reproductive age. It is most useful in women with a low pretest probability of malignancy of the adnexal mass. Studies show high diagnostic sensitivity (67-100%) and specificity (77-100%) [8] [9] [10] [11] [12] [13] [14] [15] [16] . Typical MRI protocols include T2-weighted imaging in two planes, usually the sagittal T2-weighted imaging providing overview of the uterus and the ovaries and a transaxial T1-and high-resolution fast spin echo (FSE) T2-weighted imaging sequence covering in thin slices the ovaries [7] . If the ovaries are not seen, oblique axial T2-weighted imaging taken along the long axis of the uterus will visualize the ovaries in atypical position along their ovarian axis. In equivocal cases, this plane or alternatively a coronal plane also serves in solving important differential diagnostic issues, e.g., the nonovarian origin of a parauterine mass (i.e., pedunculated uterine leiomyoma). Features of subserous uterine leiomyomas present presence of bridging vessels between the mass and the myometrium or the claw sign of the uterine myometrium. In contrast, demonstrations of follicles within or in the periphery of the mass and the ovarian beak sign are typical features of ovarian origin of a pelvic mass [7] .
The majority of adnexal lesions can be characterized by their specific signal characteristics on T1-and T2-weighted imaging. Simple fluid has homogeneous low signal on T1-weighted imaging and high SI on T2-weighted imaging. Fat and hemorrhage have high SI on T1-weighted imaging. Fat suppression (FS) on T1-weighted imaging is used to differentiate fat-containing dermoids from hemorrhagic cystic lesions [7] . In solid and in cystic adnexal masses, characterization is best performed by complementing the basic sequences with DWI and intravenous administration of gadolinium [11, 15, 16] . For characterization of adnexal masses, the recommended high b value is between 800 and 1200 mm/s 2 . Optimally, dynamic multiphase contrast-enhanced (DCE) MRI is used to characterize adnexal masses, as the time-intensity curve of a solid aspect of the mass in relation to the myometrium will provide important differential diagnostic information. Subtraction images are essential to evaluate enhancing aspects within hemorrhagic lesions, e.g., of nodules within endometriomas. Fasting for 4 h, application of antiperistaltic medication, and examination with a medium full bladder are used to optimize the image quality [7] .
Computed Tomography (CT)
In clinical practice contrast-enhanced CT is widely used to assess abdominal pathologies, and usually this is accomplished by covering the abdomen and the pelvis. For characterization of a sonographically indeterminate mass, CT is not recommended, as it is inferior to both MRI and US to assess solid and hemorrhagic masses. CT is, however, the modality of choice to stage suspected ovarian cancer [17] . Another role of CT is in the emergency setting, where it is widely used to assess the acute abdomen, for both gynecological and non-gynecological causes [18] .
Positron Emission Tomography/ Computed Tomography (PET/CT)
PET/CT using fluoro-2-deoxy-D-glucose (FDG) has currently no role in characterizing of adnexal lesions. Physiological uptake in premenopausal age in normal ovaries and in corpus luteum cysts is a well-known cause of misinterpretation [19] . FDG uptake can also be seen in benign ovarian tumors, such as dermoids, as well as in inflammatory and infectious processes. However, in postmenopausal age FDG avid uptake in the ovaries is typically associated with malignant disease. Currently the role of PET/CT includes assessment of suspected recurrence in two scenarios in patients with ovarian cancer: a) in biochemically suspected recurrence and no evidence of disease with other imaging techniques or b) to exclude systemic disease in surgical potential candidates with localized disease.
Adnexal Masses on MRI
Imaging characteristics of benign and malignant ovarian masses are summarized in Table 8 .1.
Benign Cystic Ovarian Masses

Ovarian Cysts
In reproductive age physiological ovarian cysts constitute the vast majority of adnexal masses. Ovarian follicles and follicular cysts share the same imaging features of thin-walled lesions with watery contents, but per definition the term cyst should be reserved only to those larger than 3 cm in size [1] . Due to their high prevalence in premenopausal age, cysts ranging from 3 to 5 cm do not require further follow-up, unless they are symptomatic [1] . Ovarian cysts include either follicular cysts or corpus luteum cysts. The latter derive from failure of regression or hemorrhage into the corpus luteum. Corpus luteum and corpus luteum cysts typically have a wellvascularized thicker wall that may be crenulated and often contain blood products. Thus they display a lacelike appear- ance in US and not watery contents but signal intensity of blood products on MRI (high SI on T1-weighted imaging and FS T1-weighted imaging or hemosiderin). Typical is unilaterality and regression in a 2-3 months interval.
Endometriomas
Endometriomas present endometriotic cysts of the ovaries and constitute the most common manifestation of endometriosis. Most commonly they present bilateral thick-walled unior multiloculated cystic lesions containing blood products. Pathognomonic features include high SI on T1-weighted imaging and FS T1-weighted imaging and low SI on T2-weighted imaging (shading) (Fig. 8.1 ) [20] . The T2 dark spot sign presenting focal mural clot is another typical feature [21] . As in unilocular hemorrhagic cysts the distinction between endometriomas and hemorrhagic cysts may sometimes be difficult, follow-up US is recommended. Only functional cysts will resolve. Bilaterality and multicystic appearance favor endometrioma. Adhesions with low SI bands and distortion of the ovaries, the uterus, or the bowel are other typical findings in endometriosis. As deep endometriosis, particularly involving the posterior fornix or the rectosigmoid colon, is often associated with endometriomas, this area should also be scrutinized.
Benign Teratomas (Mature Cystic Teratomas or Dermoid Cysts)
The typical finding of a mature teratoma is that of a unilocular cystic lesion containing fatty elements. Often a mural nodule, the Rokitansky nodule or dermoid plug, projects into the lesion. It is composed of a variety of tissues and typically demonstrates fat and calcifications, representing teeth or bones. A minority (approx. 15%) of mature cystic teratomas will demonstrate no fat or only small foci of fat within the wall or the Rokitansky nodule [22] .
As US features of dermoids may overlap with those of other entities, such as endometriomas or ovarian carcinomas, CT ( Fig. 8. 2) or MRI ( Fig. 8.3 ) is performed in suspected dermoids, as they allow a specific diagnosis. In both Transaxial T1-weighted imaging and (c) FS T1-weighted imaging (arrow) demonstrate high SI characteristic of internal blood products. There is no evidence of internal or mural nodularity of these techniques, identification of fat is the pivotal finding. On MRI, the fatty component will demonstrate high SI on both T1-and T2-weighted imaging, with the lipid-laden cyst fluid demonstrating a similar high SI on T1-weighted imaging and intermediate SI on T2-weighted imaging. Chemical shift artifact is often seen at the fat-fluid interface in dermoid cysts as bright or dark bands along the frequency-encoding gradient on T2-weighted imaging. Use of FS T1-weighted imaging enables dermoid cysts (which drop the SI) to be distinguished from hemorrhagic lesions or endometriomas (which retain high SI). In lipid poor dermoids chemical shift imaging techniques may assist in defining the correct diagnosis. Due to their very slow growth, surveillance is a treatment option in dermoids smaller than 5 cm in size. Rarely, malignant transformation may develop within a dermoid cyst; most frequently this is squamous cell cancer in a woman of advanced age. Capsular penetration is the most reliable sign to establish this extremely rare complication [23] .
Cystadenomas
Cystadenomas present common epithelial ovarian tumors, accounting for up to 50% of tumors in reproductive age and for up to 80% of benign ovarian tumors in postmenopausal age [24] . Both have now been recognized as precursors of ovarian cancer and may slowly transform to borderline tumors and to invasive ovarian cancer [25] . Serous cystadenomas are more common than mucinous cystadenomas. Although an overlap exists, imaging features aid in the differentiation of serous from mucinous cystadenomas [24] . In general, both entities are thin-walled cystic lesions (Fig. 8.4) . Serous cystadenomas follow the pattern of a simple cyst or of a multiseptate mass, whereas a mucinous cystadenoma is typically a large multilocular lesion with locules of various fluid contents [26] . On MRI, cysts in mucinous tumors demonstrate various signal intensities on T1-and T2-weighted imaging, giving rise to the so-called "stained-glass" appearance. This is because on T1-weighted imaging locules with watery mucin generate lower SI than locules with thicker mucin. The opposite is generated on T2-weighted imaging. Cystadenomas can be differentiated from hydrosalpinx due to their complete septations on multiplanar imaging.
Benign Solid Ovarian Tumors
These present a rare subgroup of ovarian tumors mostly comprising fibromas, thecomas, and Brenner tumors. They are usually unilateral solid ovarian tumors found in perimenopausal age [27] . In clinical practice they have to be differentiated from their mimickers, the more common pedunculated uterine leiomyomas. Signs defining the ovarian origin are pivotal for the differentiation. Due to their composition of fibrous tissue, they usually display typical features of benign adnexal masses with solid elements displaying very low SI on T2-weighted imaging. In degenerative changes including edema, cystic changes, or torsion, their differentiation from malignant masses is challenging. However, when such a solid lesion demonstrates low SI on DWI using a high b value, malignancy can be ruled out [12, 16] . Mild and slow gadolinium (type 1) enhancement pattern is seen in the majority of cases. The triad of an ovarian fibroma, ascites, and pleural effusion constitutes the benign Meigs syndrome, which can be associated with elevated CA-125. Unlike fibromas, more than half of thecomas express estrogenes and may present with uterine bleeding, endometrial hyperplasia, or endometrial cancer [27] . Dense amorphous calcifications are a typically feature in Brenner tumors in CT. 
Borderline and Malignant Ovarian Tumors
Borderline tumors account for approximately 15% of ovarian tumors. The vast majority of ovarian malignant lesions include invasive epithelial ovarian cancer and metastases. The latter constitute 15% of malignant ovarian masses and originate mostly from breast and the GI tract cancer. In contrast, sex cord-stromal tumors (granulosa cell and SertoliLeydig cell tumors) and malignant germ cell tumors are rare tumors, mostly found in young age. Borderline tumors are now considered as precursor lesions that gradually progress to different subtypes of epithelial ovarian cancer type II. Serous high-grade ovarian cancer, the most common ovarian cancer, shares features of tubal and primary peritoneal cancer. It seems to develop de novo rapidly and is characterized by rapid dissemination into the peritoneal cavity and usually presents with tumor dissemination outside the pelvis and ascites at diagnosis [28] .
Likelihood of malignancy increases with the presence of septations, mural nodules, and papillary projections (Fig. 8.5 ). MRI features suspicious for malignancy include mass 4 cm, cystic lesion with solid component, irregular wall thickness of 3 mm or more, septal thickness of 3 mm or more, presence of papillary projections or nodules, and presence of solid mass with necrosis and early, bright contrast enhancement [3, 16, 29] . In addition, ancillary criteria for suspected malignancy include direct local tissue invasion, peritoneal deposits, enlarged lymph nodes, and ascites. Dynamic CE (DCE) MRI is used for risk stratification in cystic and solid adnexal masses. Time-intensity curves types 1, 2, and 3 obtained from the solid aspects of such masses are associated with benign, borderline, and invasive tumors [16] . Gadolinium also improves peritoneal and omental implant detection in case of ovarian carcinoma. Due to the overlap of ADC values, DWI is less useful to characterize indeterminate adnexal masses, but it is pivotal to assess peritoneal carcinomatosis [14] [15] [16] [17] . CE-CT remains the technique of choice for staging ovarian carcinoma [17] (Figs. 8.6 and 8.7 ).
Risk Stratification of Adnexal Masses Using the AdnexMR Score
When interpreting an adnexal mass on MRI, an algorithmic approach is strongly advocated. A risk stratification can also be applied ( By following this approach, most masses can be allocated a score according to the risk of malignancy, allowing the best clinical management for the patient. 
Take-Home Messages
• Ultrasound is highly effective in the diagnosis of adnexal masses and can direct the treatment approach in most cases.
• It is important for radiologists to recognize the features of common benign and physiological findings.
• MRI is a second-line imaging modality which can be helpful in the characterization of sonographically indeterminate masses, acting as a problemsolving tool. • For MRI, we recommend an algorithmic approach which includes DWI and contrast-enhanced sequences with DCE as the preferred contrast technique.
